Abstract:Dynamic cerebral blood flow (CBF) regulation via neurovascular coupling (NVC) is essential to meet localized brain oxygen and nutrient demands. Cerebral microvascular dysfunction contributes to the pathogenesis of many types of dementias. Previous studies suggest that oxidative stress play a critical role in endothelial disfunction, cerebral microvascular impairments, and blunted NVC responses. Increased reactive oxidative species (ROS), inflammatory cytokines, and decreased brain blood flow contribute to the progression of both vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer's disease related dementia (ADRD).Our novel synthetic glycosylated Angiotensin-(1-7) derivative, PNA5, reverses cognitive deficits, inhibits brain ROS and inflammatory cytokine production, and limits microglial activation in our preclinical model of heart failure (HF)-induced VCID. We hypothesize that heart failure (HF) impairs cerebral vascular dilation and NVC, and that treatment with extended release PNA5 (PNA5ER) will improved cerebral vascular dilation and NVC. Adult male C57BL/6J mice (6-10/group) were subjected to HF via left anterior artery ligation or sham surgery 5 weeks prior to treatment with either 1) Vehicle (DMSO) or 2) 1.5mg PNA5ER (30uL of 50 mg/mL). Treatments were delivered subcutaneously at time= 3 weeks and again at t= 1 week prior to vascular evaluation and sacrifice. NVC was assessed using laser speckle imaging. Basal cerebral perfusion and NVC after somatosensory stimulation were assessed by laser speckle contrast imaging. NVC was calculated as a percent change in perfusion from baseline induced by stimulation. Basilar arteries were mounted on a wire myograph to assess cerebral vascular function. HF mice receiving vehicle treatment (n=2, mean= 4.41, Std Deviation=2.32) trend to have decreased NVC response compared to Sham (n=5, mean= 13.63, Std Deviation= 10.35), which may be rescued by PNA5ER (n=3, mean= 10.32, Std Deviation= 4.499). Endothelium-dependent dilation of basilar arteries, induced by cumulative concentrations of NS309 and 2-Methylthio-ADP, was impaired in HF compared to Sham mice; PNA5ER improved vasodilatory responses in the basilar artery.Our preliminary data suggest that PNA5ER protects against NVC impairments and improves basilar artery vasodilation in mice with HF-induced VCID, thereby potentially increasing the ability of the vasculature to meet the localized metabolic demands of the brain. Supported by NIA This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Neuroprotective Effects of VEGF-A Nanofiber Membrane and FAAH Inhibitor URB597 Against Oxygen–Glucose Deprivation-Induced Ischemic Neuronal Injury

VEGF Loaded Nanofiber Membranes Inhibit Chronic Cerebral Hypoperfusion-Induced Cognitive Dysfunction by Promoting HIF-1a/VEGF Mediated Angiogenesis.

Sustained Release of Vascular Endothelial Growth Factor A and Basic Fibroblast Growth Factor from Nanofiber Membranes Reduces Oxygen/glucose Deprivation-Induced Injury to Neurovascular Units.

Combined VEGF and Bfgf Loaded Nanofiber Membrane Protects Against Neuronal Injury and Hypomyelination in a Rat Model of Chronic Cerebral Hypoperfusion

VEGF-A ameliorates ischemia hippocampal neural injury via regulating autophagy and Akt/CREB signaling in a rat model of chronic cerebral hypoperfusion

VEGF Ameliorates Cognitive Impairment in In Vivo and In Vitro Ischemia via Improving Neuronal Viability and Function

VEGF attenuates 2-VO induced cognitive impairment and neuronal injury associated with the activation of PI3K/Akt and Notch1 pathway.

Neuronal Injury in Rat Model of Permanent Focal Cerebral Ischemia is Associated with Activation of Autophagic and Lysosomal Pathways.

URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen-Glucose Deprivation

The Protective Effects of Axitinib on Blood-Brain Barrier Dysfunction and Ischemia-Reperfusion Injury in Acute Ischemic Stroke

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

Preservation of spatial memory and neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia

Adeno-Associated Viral Vector-Mediated Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury after Focal Cerebral Ischemia in Mice

Vascular endothelial growth factor is neuroprotective against ischemic brain injury by inhibiting scavenger receptor A expression on microglia

VEGF Modulates the Neural Dynamics of Hippocampal Subregions in Chronic Global Cerebral Ischemia Rats

Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs

Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2

A novel therapeutic Ang(1-7) analogue improves neurovascular function in mice with vascular contributions to cognitive impairment and dementia

Molecular and Cellular Mechanisms of Neuroprotection by Vascular Endothelial Growth Factor.

Adenoviral Vector-Mediated Transduction of Vegf Improves Neural Functional Recovery after Hypoxia-Ischemic Brain Damage in Neonatal Rats

Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury